These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 16813445)

  • 1. Squeezing flows of vaginal gel formulations relevant to microbicide drug delivery.
    Kieweg SL; Katz DF
    J Biomech Eng; 2006 Aug; 128(4):540-53. PubMed ID: 16813445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gravity-induced coating flows of vaginal gel formulations: in vitro experimental analysis.
    Kieweg SL; Geonnotti AR; Katz DF
    J Pharm Sci; 2004 Dec; 93(12):2941-52. PubMed ID: 15459949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interpreting properties of microbicide drug delivery gels: analyzing deployment kinetics due to squeezing.
    Kieweg SL; Katz DF
    J Pharm Sci; 2007 Apr; 96(4):835-50. PubMed ID: 17094142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dilution of microbicide gels with vaginal fluid and semen simulants: effect on rheological properties and coating flow.
    Lai BE; Xie YQ; Lavine ML; Szeri AJ; Owen DH; Katz DF
    J Pharm Sci; 2008 Feb; 97(2):1030-8. PubMed ID: 17724667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimisation of polyherbal gels for vaginal drug delivery by Box-Behnken statistical design.
    Chopra S; Motwani SK; Iqbal Z; Talegaonkar S; Ahmad FJ; Khar RK
    Eur J Pharm Biopharm; 2007 Aug; 67(1):120-31. PubMed ID: 17270408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biophysical analysis of prototype microbicidal gels.
    Owen DH; Peters JJ; Kieweg SL; Geonnotti AR; Schnaare RL; Katz DF
    J Pharm Sci; 2007 Mar; 96(3):661-9. PubMed ID: 17131365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial to determine the distribution of four topical gel formulations in the human vagina.
    Barnhart K; Kulp JL; Rosen M; Shera DM
    Contraception; 2009 Apr; 79(4):297-303. PubMed ID: 19272499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaginal deployment and tenofovir delivery by microbicide gels.
    Gao Y; Yuan A; Chuchuen O; Ham A; Yang KH; Katz DF
    Drug Deliv Transl Res; 2015 Jun; 5(3):279-94. PubMed ID: 25874971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chitosan and a modified chitosan as agents to improve performances of mucoadhesive vaginal gels.
    Perioli L; Ambrogi V; Venezia L; Pagano C; Ricci M; Rossi C
    Colloids Surf B Biointerfaces; 2008 Oct; 66(1):141-5. PubMed ID: 18621512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of a vaginal gel (Invisible Condom) before, during and after simulated sexual intercourse and its persistence when delivered by two different vaginal applicators: a magnetic resonance imaging study.
    Omar RF; Trottier S; Brousseau G; Lamarre A; Alexandre Gagnon ; Bergeron MG
    Contraception; 2008 Jun; 77(6):447-55. PubMed ID: 18477496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in development, scale-up and manufacturing of microbicide gels, films, and tablets.
    Garg S; Goldman D; Krumme M; Rohan LC; Smoot S; Friend DR
    Antiviral Res; 2010 Dec; 88 Suppl 1():S19-29. PubMed ID: 21109064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transport theory for HIV diffusion through in vivo distributions of topical microbicide gels.
    Lai BE; Henderson MH; Peters JJ; Walmer DK; Katz DF
    Biophys J; 2009 Nov; 97(9):2379-87. PubMed ID: 19883580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Universal vaginal applicator for the uniform distribution of vaginal gel and cream formulations: a magnetic resonance imaging study.
    Omar RF; Trottier S; Brousseau G; Ouellet C; Danylo A; Ong T; Bergeron MG
    J Obstet Gynaecol Can; 2014 Jan; 36(1):42-50. PubMed ID: 24444286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal toxicity studies of a gel formulation of native pokeweed antiviral protein.
    D'Cruz OJ; Waurzyniak B; Uckun FM
    Toxicol Pathol; 2004; 32(2):212-21. PubMed ID: 15200159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optical imaging and analysis of human vaginal coating by drug delivery gels.
    Henderson MH; Couchman GM; Walmer DK; Peters JJ; Owen DH; Brown MA; Lavine ML; Katz DF
    Contraception; 2007 Feb; 75(2):142-51. PubMed ID: 17241845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and in vitro evaluation of a vaginal microbicide gel formulation for UAMC01398, a novel diaryltriazine NNRTI against HIV-1.
    Grammen C; Ariën KK; Venkatraj M; Joossens J; Van der Veken P; Heeres J; Lewi PJ; Haenen S; Augustyns K; Vanham G; Augustijns P; Brouwers J
    Antiviral Res; 2014 Jan; 101():113-21. PubMed ID: 24269474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erosion of microbicide formulation coating layers: effects of contact and shearing with vaginal fluid or semen.
    Geonnotti AR; Peters JJ; Katz DF
    J Pharm Sci; 2005 Aug; 94(8):1705-12. PubMed ID: 15986472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subchronic (26- and 52-week) toxicity and irritation studies of a novel microbicidal gel formulation containing sodium lauryl sulfate in animal models.
    Piret J; Laforest G; Bussières M; Bergeron MG
    J Appl Toxicol; 2008 Mar; 28(2):164-74. PubMed ID: 17549701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucoadhesive nanosystems for vaginal microbicide development: friend or foe?
    das Neves J; Amiji M; Sarmento B
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2011; 3(4):389-99. PubMed ID: 21506290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modified silicone elastomer vaginal gels for sustained release of antiretroviral HIV microbicides.
    Forbes CJ; McCoy CF; Murphy DJ; Woolfson AD; Moore JP; Evans A; Shattock RJ; Malcolm RK
    J Pharm Sci; 2014 May; 103(5):1422-32. PubMed ID: 24585370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.